ARTG Entry
LIPOSOMAL
ARTG entry for LIPOSOMAL (doxorubicin hydrochloride), ARTG 202827 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: Sun Pharma
- Active ingredient: doxorubicin hydrochloride
- Therapeutic area: Oncology
What it is
Liposomal Doxorubicin Sun is a doxorubicin hydrochloride liposome injection concentrate.
Regulatory history
Liposomal Doxorubicin Sun was first listed on the ARTG on 11 December 2013. Two strengths are registered: 20 mg/10 mL and 50 mg/25 mL in glass vials.